Sanofi SA
NASDAQ:SNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
NASDAQ:SNY
|
FR |
|
T
|
Trip.com Group Ltd
SWB:CLV
|
SG |
|
Stora Enso Oyj
F:ENUS
|
FI |
|
S
|
Santam Ltd
JSE:SNT
|
ZA |
|
Globant SA
NYSE:GLOB
|
LU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNY's stock price target?
Price Target
55.678
USD
According to Wall Street analysts, the average 1-year price target for
SNY is 55.678 USD with a low forecast of 33.61 USD and a high forecast of 68.656 USD.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 5%.
What is the Pre-Tax Income forecast for Sanofi SA?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 32%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 6%.